Orthopedic braces are devices which are used to support and control
the joints of the body. The braces can be used on the ankle, knee, hip,
back, neck, elbow, fingers, and wrist. Orthopedic braces are used to
control the position of limbs and initiate specific movement or motion
in the body. Also, the braces can be compensated for weak muscles and to
correct structural deformities. Orthopedic braces are used extensively
for diagnosis of cerebral palsy, spina bifida, spinal cord injury,
scoliosis, and to deal with after stroke effects. Braces are also used
after surgeries on knee joints in order to keep the joints immobile and
control motion until the joints recover. Many people use braces for
extra support to prevent injuries to joints. Athletes such as football
and rugby players’ particularly use braces to prevent injuries. The
sophisticated designs, cost effectiveness, and easy availability are
driving the growth of the OTC orthopedic braces market. Custom braces
and relevant designs can increase the cost of braces which may restrain
the OTC orthopedic braces market growth rate during the forecast period.
Orthotics is an example which is more than a shoe inserts. Orthotics
manufacture and design orthoses which modifies the structure and
function of the skeletal and neuromuscular system of the body. Demand
for orthopedic braces has increased due to increase in the geriatric
population, obesity, rising public participation in sports, orthopedic
injuries among younger population, and rise in incidence of bone
-degenerative diseases, all of which are driving growth in the OTC
orthopedic braces market. According to the American Journal of
Orthopedics, August 2016, osteoarthritis is a leading cause of
disability among middle-aged and older adults, affecting nearly 27
million Americans. Increase in aging of the baby boomer population and
rising obesity rates are estimated to increase osteoarthritis by 40% by
2025. Moreover, noninvasive nature of treatment using orthopedic braces
and supports, reduced reimbursements offered during orthopedic surgery
in developed regions such as North America and Europe are expected to
propel the growth opportunities for sports players representing at a
global, national or state level. High patient preference for alternative
treatments, supports in prophylactic and rehabilitative use and lack of
customization options for OTC orthopedic braces can hamper the growth
of the global OTC orthopedic brace market during the forecast period.
The OTC orthopedic braces market has been segmented by product type,
indication, end-users, and geography. In terms of product type, the OTC
orthopedic braces market is classified into foot & ankle braces,
upper extremity braces, knee braces, and spinal orthoses braces. In
terms of indication type, the market is classified into injury,
arthritis, prophylactic, and others. According to the professor of
Boston University School of Medicine, knee osteoarthritis is progressive
damage to joint cartilage which leads to weakened muscles, pain and
swelling. People who wore knee braces reduced pain by about 40% over 6
weeks. In terms of end users, the OTC orthopedic braces market is
classified into orthopedic clinics, hospitals, pharmacies, and others.
Geographically, the OTC orthopedic braces market is classified into
North America, Latin America, Europe, Asia Pacific, and Middle East
& Africa.
Geographically North America dominates the global OTC orthopedic braces reagents market due to increase in obesity, increase in sports activity, and rise in aging population. Reduced reimbursement policy for surgeries and low cost of braces is expected to drive the OTC orthopedic braces reagents market in North America. Europe is the second largest market for OTC orthopedic braces reagents as there are favorable government policies regarding healthcare infrastructure and awareness programs. Asia Pacific is expected to grow at a higher rate due to rising population, changing lifestyles, rising interest in sports activity among the population, and increasing per capita expenditure. In addition, economic growth is supporting healthcare infrastructure improvement in developing countries such as Brazil, India, and China. Thus, all these factors collectively support the growth of the OTC orthopedic braces reagents market in Asia Pacific and Latin America.
The major players operating in the global OTC orthopedic braces reagents market include ALCARE Co., Ltd., DJO Finance LLC, DeRoyal Industries Inc., Ossur hf., Breg, Inc., 3M Company, Otto Bock HealthCare, Bauerfeind AG, BSN Medical, medi GmbH & Co. KG, and Thuasne Group.
Geographically North America dominates the global OTC orthopedic braces reagents market due to increase in obesity, increase in sports activity, and rise in aging population. Reduced reimbursement policy for surgeries and low cost of braces is expected to drive the OTC orthopedic braces reagents market in North America. Europe is the second largest market for OTC orthopedic braces reagents as there are favorable government policies regarding healthcare infrastructure and awareness programs. Asia Pacific is expected to grow at a higher rate due to rising population, changing lifestyles, rising interest in sports activity among the population, and increasing per capita expenditure. In addition, economic growth is supporting healthcare infrastructure improvement in developing countries such as Brazil, India, and China. Thus, all these factors collectively support the growth of the OTC orthopedic braces reagents market in Asia Pacific and Latin America.
The major players operating in the global OTC orthopedic braces reagents market include ALCARE Co., Ltd., DJO Finance LLC, DeRoyal Industries Inc., Ossur hf., Breg, Inc., 3M Company, Otto Bock HealthCare, Bauerfeind AG, BSN Medical, medi GmbH & Co. KG, and Thuasne Group.
No comments:
Post a Comment